NYSE:BSXMedical Equipment
Boston Scientific (NYSE:BSX) Expands FARAPULSE System FDA Approval For Persistent Atrial Fibrillation
Boston Scientific (NYSE:BSX) recently achieved FDA approval to expand the FARAPULSE™ Pulsed Field Ablation (PFA) System's use, enhancing treatment options for persistent atrial fibrillation. This significant development aligns with the 15% share price increase over the last quarter. The company's inclusion in key Russell indices and positive clinical trial results may have amplified its stock performance. While the broader market experienced growth, Boston Scientific's strategic advancements...